Pharmaceuticals

EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries

PROVIDENCE, Rhode Island, April 8, 2020 /PRNewswire/ -- EpiVax, Inc., is using advanced computational tools to accelerate a COVID-19 vaccine candidate (EPV-CoV19) for healthcare workers (HCW) into clinical trials in 6 months. Today, EpiVax announces its partnership with GAIA Vaccine Foundation ("...

2020-04-08 03:57 550

HOYA/PENTAX Medical Issues Statement Regarding U.S. Department of Justice Settlement

MONTVALE, New Jersey and TOKYO, April 7, 2020 /PRNewswire/ -- HOYA Corporation and a subsidiary through PENTAX Medical division, Pentax of America, Inc. (collectively, "PENTAX" or "the Company"), today finalized a Deferred Prosecution Agreement (DPA) with the U.S. Department of Justice (DOJ) on i...

2020-04-07 23:36 658

Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study

SYDNEY, April 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share positive interim data from its ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most common and most agg...

2020-04-07 20:00 1596

CROMSOURCE Announces Launch of COVID-19 Clinical Trial

VERONA, Italy, 7 April, 2020 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) with its global headquarters inVerona, Italy, has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company. This trial is expected to be pe...

2020-04-07 19:01 614

INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today

- Up to 40 Healthy Volunteers To Participate at Two Trial Locations - Preclinical Animal Studies Show Promising Immune Responses - Rapid Advancement Possible Through a Global Coalition of Collaborators, Partners, and Funders PLYMOUTH MEETING, Pennsylvania, April 6, 2020 /PRNewswire/ -- INOVIO...

2020-04-06 20:30 885

Yuyu Pharma appoints Robert Wonsang Yu as incoming President and CEO

SEOUL, South Korea, April 5, 2020 /PRNewswire/ -- Yuyu Pharma (KRX: 000220), a global pharmaceutical company based in Korea, is pleased to announce the appointment of Mr.Robert Wonsang Yu as President and Chief Executive Officer effectiveApril 6, 2020.

2020-04-06 08:00 358

COVID-19 Antibody Test Released by Ortho Clinical Diagnostics

RARITAN, New Jersey, April 4, 2020 /PRNewswire/ -- Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 To...

2020-04-04 07:06 1427

Seneca Biopharma, Inc. Announces the Completion of Stem Cell Manufacturing Facility in China

GERMANTOWN, Maryland, April 3, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced the completion of its new cell manufacturing facility in Suzhou,China. The facilit...

2020-04-03 20:00 945

CPhI & P-MEC China 2020 will join hands with P-Logi China 2020 and be held at Shanghai New International Expo Center in June

SHANGHAI, April 3, 2020 /PRNewswire/ -- To provide global vision and opportunities for the intelligent coordination between pharmaceutical enterprises and logistics service and equipment suppliers, P-Logi China 2020, organized by Informa Markets and CCCMHPIE and co-organized by Sinoexpo Informa ...

2020-04-03 17:02 1095

CMAB Biopharma Appoints Mr. Ye Shi as Head of Quality

SUZHOU, China, April 3, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Mr. Ye Shi as the Head of Quality. He will be responsible for the overall management of the qual...

2020-04-03 09:12 1673

China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma

-- XEN® Becomes the First Medical Product Approved by Using Real World Evidence inChina -- DUBLIN, April 2, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN® Gel Stent on March 26, 202...

2020-04-02 19:30 5872

Covid-19 Related Delays in the Ongoing Phase IIb-study are Expected to be Managed With Existing Funding

STOCKHOLM, April 2, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, onApril 2 2020, that the company is now seeing signs of delays in the ongoing clinical phase IIb study with the drug candidate RV001 in prostate cancer, due to the Covid-19 pandemic. However, the company believes that ...

2020-04-02 17:17 760

Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020

HANGZHOU and SHAOXING, China, April 1, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its partner Sagimet Biosciences (formerly 3-V Biosciences, Inc), will present clinical and preclinical data on non-alcoholic steatohepatitis (NASH) drug candidate TVB-2640 (Ascl...

2020-04-01 08:30 962

Saxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity

BAGSVÆRD, Denmark, April 1, 2020 /PRNewswire/ -- Novo Nordisk today announced that theNew England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda® (liraglutide 3.0 mg) in adolescents (aged 12–<18) with obesity.1 The study was accepted for pr...

2020-04-01 00:00 270

Yuyu Pharma introduces enhanced ERP system

SEOUL, South Korea, March 31, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) introduced a new Enterprise Resource Planning (ERP) system to identify real-time management conditions and enhance system management for more efficient decision-making.

2020-03-31 21:00 327

Yiling Pharmacy Lianhua Qingwen has been approved by the Ministry of Health of Thailand

SHIJIAZHUANG, China, March 31, 2020 /PRNewswire/ -- On March 31, Shijiazhuang Yiling Pharmaceutical Co., Ltd released a notice that they had received the approval of the modern herbal medicine registration issued by the ministry of health ofThailand. Lianhua Qingwen Capsule is recognized as in li...

2020-03-31 18:15 515

Fosun Pharma Announces 2019 Annual Results

SHANGHAI, March 31, 2020 /PRNewswire/ -- On March 30 2020, Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK), a leading healthcare group in China, announced its annual results for the year 2019 ("the reporting period"). During the reporting period: ...

2020-03-31 17:51 8949

Yuyu Pharma introduces new advanced ERP management system

SEOUL, South Korea, March 31, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) introduced a new Enterprise Resource Planning (ERP) system to identify real-time management conditions and enhance system management for more efficient decision-making. The new ERP system took more...

2020-03-31 16:00 312

3SBio Unveils 2019 Annual Results: Revenue Rises by 16.0%, Normalized Net Profit attributable to owners of the parent Jumps by19.4%, R&D Expenses Soar 45.2%

HONGKONG, March 31, 2020 /PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today released its 2019 annual results, showing that the Company maintained steady growth, with core products continuously leading the market and more products being included into drug reimbursemen...

2020-03-31 12:29 7078

Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed Global Clinical Development Group

SYDNEY, March 31, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies O'Bryan-Tear will be chairing Clarity's newly formed Global Clinical Development group. Dr O'Bryan-Tear joined the pha...

2020-03-31 12:10 514
12345 ... 112